CA
SRTA icon

Clearstead Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Clearstead Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22 Buy
+4
New +$21 ﹤0.01% 3572
2026
Q1 		– Sell
-224
Closed -$1.08K – 2328
2025
Q4 		$1.08K Buy
224
+220
+5,500% +$1.06K ﹤0.01% 2222
2025
Q3 		$21 Buy
+4
New +$18 ﹤0.01% 3020

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearstead Advisors's SRTA Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 4 shares worth $22. The stake represents ﹤0.01% of the portfolio and ranks #3572 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in SRTA as recently as Q4 2025.

Clearstead Advisors first reported a position in SRTA in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.08K in Q4 2025. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Clearstead Advisors held 4 shares of Strata Critical Medical Inc worth $22 as of Q2 2026.
  • Strata Critical Medical Inc was a new Clearstead Advisors position in Q2 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3572 holding.
  • Clearstead Advisors first reported a position in Strata Critical Medical Inc in Q3 2025 and has held it in 3 quarters since.
  • Clearstead Advisors's Strata Critical Medical Inc position peaked at $1.08K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.